XML 42 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value of Assets and Liabilities (Tables)
12 Months Ended
Dec. 31, 2017
Fair Value Disclosures [Abstract]  
Fair Value, Assets and Liabilities Measured on Recurring Basis
The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated.
 
 
As of December 31, 2017
 
 
Level 1
 
Level 2
 
Level 3
 
Netting(1)
 
Total
 
 
(in thousands)
Fixed maturities, available-for-sale:
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities and obligations of U.S. government authorities and agencies
 
$
0

 
$
80,611

 
$
19,204

 
$
0

 
$
99,815

Obligations of U.S. states and their political subdivisions
 
0

 
635,458

 
0

 
0

 
635,458

Foreign government bonds
 
0

 
134,924

 
174

 
0

 
135,098

U.S. corporate public securities
 
0

 
1,779,935

 
1,154

 
0

 
1,781,089

U.S. corporate private securities
 
0

 
901,080

 
60,158

 
0

 
961,238

Foreign corporate public securities
 
0

 
182,243

 
209

 
0

 
182,452

Foreign corporate private securities
 
0

 
837,766

 
13,900

 
0

 
851,666

Asset-backed securities(4)
 
0

 
71,400

 
111,028

 
0

 
182,428

Commercial mortgage-backed securities
 
0

 
322,832

 
0

 
0

 
322,832

Residential mortgage-backed securities
 
0

 
71,226

 
0

 
0

 
71,226

Subtotal
 
0

 
5,017,475

 
205,827

 
0

 
5,223,302

Trading account assets:
 
 
 
 
 
 
 
 
 
 
Corporate securities
 
0

 
38,793

 
0

 
0

 
38,793

Asset-backed securities(4)
 
0

 
0

 
0

 
0

 
0

Equity securities
 
0

 
0

 
17,488

 
0

 
17,488

Subtotal
 
0

 
38,793

 
17,488

 
0

 
56,281

Equity securities, available-for-sale
 
94

 
22,991

 
37

 
0

 
23,122

Short-term investments
 
0

 
0

 
1,339

 
0

 
1,339

Cash equivalents
 
0

 
28,007

 
0

 
0

 
28,007

Other long-term investments(6)
 
0

 
115,094

 
0

 
(115,086
)
 
8

Reinsurance recoverables(5)
 
0

 
0

 
5,457,649

 
0

 
5,457,649

Receivables from parent and affiliates
 
0

 
132,571

 
0

 
0

 
132,571

Subtotal excluding separate account assets
 
94

 
5,354,931

 
5,682,340

 
(115,086
)
 
10,922,279

Separate account assets(2)(7)
 
0

 
125,543,035

 
0

 
0

 
125,543,035

Total assets
 
$
94

 
$
130,897,966

 
$
5,682,340

 
$
(115,086
)
 
$
136,465,314

Future policy benefits(3)
 
$
0

 
$
0

 
$
5,452,583

 
$
0

 
$
5,452,583

Policyholders' account balances
 
0

 
0

 
46,651

 
0

 
46,651

Payables to parent and affiliates
 
0

 
74,378

 
0

 
(69,718
)
 
4,660

Total liabilities
 
$
0

 
$
74,378

 
$
5,499,234

 
$
(69,718
)
 
$
5,503,894


 
 
As of December 31, 2016
 
 
Level 1
 
Level 2
 
Level 3
 
Netting(1)
 
Total
 
 
(in thousands)
Fixed maturities, available-for-sale:
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities and obligations of U.S. government authorities and agencies
 
$
0

 
$
160,740

 
$
0

 
$
0

 
$
160,740

Obligations of U.S. states and their political subdivisions
 
0

 
626,486

 
0

 
0

 
626,486

Foreign government bonds
 
0

 
108,782

 
0

 
0

 
108,782

U.S. corporate public securities
 
0

 
2,306,409

 
55,109

 
0

 
2,361,518

U.S. corporate private securities
 
0

 
851,585

 
32,699

 
0

 
884,284

Foreign corporate public securities
 
0

 
221,848

 
0

 
0

 
221,848

Foreign corporate private securities
 
0

 
584,268

 
14,748

 
0

 
599,016

Asset-backed securities(4)
 
0

 
169,160

 
19,856

 
0

 
189,016

Commercial mortgage-backed securities
 
0

 
382,671

 
0

 
0

 
382,671

Residential mortgage-backed securities
 
0

 
83,188

 
0

 
0

 
83,188

Subtotal
 
0

 
5,495,137

 
122,412

 
0

 
5,617,549

Trading account assets:
 
 
 
 
 
 
 
 
 
 
Corporate securities
 
0

 
19,256

 
0

 
0

 
19,256

Asset-backed securities(4)
 
0

 
302

 
0

 
0

 
302

Commercial mortgage-backed securities
 
0

 
0

 
0

 
0

 

Equity securities
 
0

 
0

 
15,770

 
0

 
15,770

Subtotal
 
0

 
19,558

 
15,770

 
0

 
35,328

Equity securities, available-for-sale
 
41

 
16,640

 
75

 
0

 
16,756

Short-term investments
 
31,007

 
5,650

 
0

 
0

 
36,657

Cash equivalents
 
5,644

 
1,998

 
0

 
0

 
7,642

Other long-term investments(6)
 
0

 
90,884

 
0

 
(13,019
)
 
77,865

Reinsurance recoverables
 
0

 
0

 
5,474,263

 
0

 
5,474,263

Receivables from parent and affiliates
 
0

 
131,144

 
6,493

 
0

 
137,637

Subtotal excluding separate account assets
 
36,692

 
5,761,011

 
5,619,013

 
(13,019
)
 
11,403,697

Separate account assets(2)(7)
 
0

 
116,040,888

 
0

 
0

 
116,040,888

Total assets
 
$
36,692

 
$
121,801,899

 
$
5,619,013

 
$
(13,019
)
 
$
127,444,585

Future policy benefits(3)
 
$
0

 
$
0

 
$
5,041,007

 
$
0

 
$
5,041,007

Policyholders' account balances
 
0

 
0

 
20,337

 
0

 
20,337

Payables to parent and affiliates
 
0

 
12,854

 
0

 
(12,854
)
 
0

Total liabilities
 
$
0

 
$
12,854

 
$
5,061,344

 
$
(12,854
)
 
$
5,061,344

(1)
“Netting” amounts represent cash collateral of $45.4 million and $0.2 million as of December 31, 2017 and 2016, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting arrangements.
(2)
Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company’s Consolidated Statements of Financial Position.
(3)
As of December 31, 2017, the net embedded derivative liability position of $5,453 million includes $823 million of embedded derivatives in an asset position and $6,276 million of embedded derivatives in a liability position. As of December 31, 2016, the net embedded derivative liability position of $5,041 million includes $1,157 million of embedded derivatives in an asset position and $6,198 million of embedded derivatives in a liability position.
(4)
Includes credit-tranched securities collateralized by syndicated bank loans, sub-prime mortgages, auto loans, credit cards, education loans and other asset types.
(5)
Effective July 1, 2017, the Company recaptured the risks related to the no-lapse guarantees that were previously reinsured to UPARC and discontinued the embedded derivative accounting.
(6)
Other long-term investments excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. At December 31, 2017 and December 31, 2016, the fair values of these investments, which include certain hedge funds, private equity funds and other funds were $0.7 million and $0.9 million, respectively.
(7)
Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate owned life insurance fund, for which fair value is measured at net asset value per share (or its equivalent). At December 31, 2017 and December 31, 2016, the fair values of separate account assets excluded from the fair value hierarchy were $4,113 million and $566 million, respectively.
Fair Value Inputs, Assets, Quantitative Information
The tables below present quantitative information on significant internally-priced Level 3 assets and liabilities.
 
As of December 31, 2017
 
Fair Value  
 
  Valuation  
Techniques
 
Unobservable 
Inputs  
 
Minimum  
 
Maximum  
 
  Weighted  
Average
 
  Impact of 
Increase in 
Input on 
Fair Value(1)
 
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate securities(12)
$
36,966

 
Discounted cash flow
 
Discount rate
 
5.06
%
 
 
22.23
%
 
 
7.33
%
 
 
Decrease
 
 
 
Liquidation
 
Liquidation value
 
25
%
 
 
25
%
 
 
25
%
 
 
Increase
Reinsurance recoverables(13)
$
5,457,649

 
Fair values are determined in the same manner as future policy benefits
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future policy benefits(7)
$
5,452,583

 
Discounted cash flow
 
Lapse rate(8)
 
1
%
 
 
12
%
 
 
 
 
 
Decrease
 
 
 
 
 
Spread over LIBOR(4)
 
0.12
%
 
 
1.10
%
 
 
 
 
 
Decrease
 
 
 
 
 
Utilization rate(9)
 
52
%
 
 
97
%
 
 
 
 
 
Increase
 
 
 
 
 
Withdrawal rate
 
See table footnote (10) below
 
 
 
 
 
Mortality rate(11)
 
0
%
 
 
14
%
 
 
 
 
 
Decrease
 
 
 
 
 
Equity volatility curve
 
13
%
 
 
24
%
 
 
 
 
 
Increase
 
 
As of December 31, 2016
 
Fair Value
 
Valuation 
Techniques
 
Unobservable 
Inputs   
 
Minimum
 
Maximum
 
Weighted
Average
 
Impact of 
Increase in Input on Fair Value(1)
 
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate securities(12)
$
45,715

 
Discounted cash flow
 
Discount rate
 
4.54
%
 
 
15.00
%
 
 
8.06
%
 
 
Decrease
 
 
 
Market comparables
 
EBITDA multiples(2)
 
4.0

X
 
4.0

X
 
4.0

X
 
Increase
 
 
 
Liquidation
 
Liquidation value
 
98.21
%
 
 
98.21
%
 
 
98.21
%
 
 
Increase
Reinsurance recoverables - Living Benefits
$
5,041,262

 
Fair values are determined in the same manner as future policy benefits
Reinsurance recoverables - No Lapse Guarantee
$
433,001

 
Discounted cash flow
 
Lapse rate(3)
 
0
%
 
 
12
%
 
 
 
 
 
Decrease
 
 
 
 
 
Spread over LIBOR(4)
 
0.25
%
 
 
1.50
%
 
 
 
 
 
Decrease
 
 
 
 
 
Mortality rate(5)
 
0
%
 
 
31
%
 
 
 
 
 
Decrease
 
 
 
 
 
Premium payment(6)
 
0.65
X
 
0.95
X
 
 
 
 
Decrease
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future policy benefits(7)
$
5,041,007

 
Discounted cash flow
 
Lapse rate(8)
 
0
%
 
 
13
%
 
 
 
 
 
Decrease
 
 
 
 
 
Spread over LIBOR(4)
 
0.25
%
 
 
1.50
%
 
 
 
 
 
Decrease
 
 
 
 
 
Utilization rate(9)
 
52
%
 
 
96
%
 
 
 
 
 
Increase
 
 
 
 
 
Withdrawal rate
 
See table footnote (10) below
 
 
 
 
 
Mortality rate(11)
 
0
%
 
 
14
%
 
 
 
 
 
Decrease
 
 
 
 
 
Equity volatility curve
 
16
%
 
 
25
%
 
 
 
 
 
Increase
(1)
Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table.
(2)
Represents multiples of earnings before interest, taxes, depreciation and amortization, ("EBITDA"), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments.
(3)
For universal life, lapse rates vary based on funding level and other factors. Rates are set to zero when the no lapse guarantee is fully funded and the cash value is zero.
(4)
The spread over LIBOR swap curve represents the premium added to the risk-free discount rate (i.e., LIBOR) to reflect our estimates of rates that a market participant would use to value the living benefit contracts in both the accumulation and payout phases. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because both funding agreements and living benefit contracts are insurance liabilities and are therefore senior to debt.
(5)
Universal life mortality rates are adjusted based on underwriting information. A mortality improvement assumption is also incorporated into the projection.
(6)
For universal life, policyholders are assumed to pay a multiple of commissionable target premium levels (shown above and indicated as "X"). The multiples vary by funding level and policy duration. If the resulting premium in any duration is smaller than the minimum annual premium required to maintain the no-lapse guarantee, policyholders are assumed to pay the minimum annual premium. Policyholders are assumed to stop premium payments once the no-lapse guarantee is fully funded. The range shown as of December 31, 2016 excludes multiples for the first duration since all contracts are beyond the first duration. Assumption ranges for prior periods include first duration multiples.
(7)
Future policy benefits primarily represent general account liabilities for the living benefit guarantees of the Company’s variable annuity contracts which are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.
(8)
Lapse rates are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates are also generally assumed to be lower for the period where surrender charges apply.
(9)
The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration, and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits.
(10)
The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions may vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of December 31, 2017 and 2016, the minimum withdrawal assumption rate is 78% and the maximum withdrawal assumption rate may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%.
(11)
Range reflects the mortality rate for the vast majority of business with living benefits, with policyholders ranging from 35 to 90 years old. While the majority of living benefits have a minimum age requirement, certain benefits do not have an age restriction. This results in contractholders for certain benefits with mortality rates approaching 0%. Based on historical experience, the Company applies a set of age and duration specific mortality rate adjustments compared to standard industry tables. A mortality improvement assumption is also incorporated into the overall mortality table.
(12)
Includes assets classified as fixed maturities available-for-sale.
(13)
Effective July 1, 2017, the Company recaptured the risks related to the no-lapse guarantees that were previously reinsured to UPARC and discontinued the embedded derivative accounting.
Fair Value Inputs, Liabilities, Quantitative Information
The tables below present quantitative information on significant internally-priced Level 3 assets and liabilities.
 
As of December 31, 2017
 
Fair Value  
 
  Valuation  
Techniques
 
Unobservable 
Inputs  
 
Minimum  
 
Maximum  
 
  Weighted  
Average
 
  Impact of 
Increase in 
Input on 
Fair Value(1)
 
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate securities(12)
$
36,966

 
Discounted cash flow
 
Discount rate
 
5.06
%
 
 
22.23
%
 
 
7.33
%
 
 
Decrease
 
 
 
Liquidation
 
Liquidation value
 
25
%
 
 
25
%
 
 
25
%
 
 
Increase
Reinsurance recoverables(13)
$
5,457,649

 
Fair values are determined in the same manner as future policy benefits
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future policy benefits(7)
$
5,452,583

 
Discounted cash flow
 
Lapse rate(8)
 
1
%
 
 
12
%
 
 
 
 
 
Decrease
 
 
 
 
 
Spread over LIBOR(4)
 
0.12
%
 
 
1.10
%
 
 
 
 
 
Decrease
 
 
 
 
 
Utilization rate(9)
 
52
%
 
 
97
%
 
 
 
 
 
Increase
 
 
 
 
 
Withdrawal rate
 
See table footnote (10) below
 
 
 
 
 
Mortality rate(11)
 
0
%
 
 
14
%
 
 
 
 
 
Decrease
 
 
 
 
 
Equity volatility curve
 
13
%
 
 
24
%
 
 
 
 
 
Increase
 
 
As of December 31, 2016
 
Fair Value
 
Valuation 
Techniques
 
Unobservable 
Inputs   
 
Minimum
 
Maximum
 
Weighted
Average
 
Impact of 
Increase in Input on Fair Value(1)
 
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate securities(12)
$
45,715

 
Discounted cash flow
 
Discount rate
 
4.54
%
 
 
15.00
%
 
 
8.06
%
 
 
Decrease
 
 
 
Market comparables
 
EBITDA multiples(2)
 
4.0

X
 
4.0

X
 
4.0

X
 
Increase
 
 
 
Liquidation
 
Liquidation value
 
98.21
%
 
 
98.21
%
 
 
98.21
%
 
 
Increase
Reinsurance recoverables - Living Benefits
$
5,041,262

 
Fair values are determined in the same manner as future policy benefits
Reinsurance recoverables - No Lapse Guarantee
$
433,001

 
Discounted cash flow
 
Lapse rate(3)
 
0
%
 
 
12
%
 
 
 
 
 
Decrease
 
 
 
 
 
Spread over LIBOR(4)
 
0.25
%
 
 
1.50
%
 
 
 
 
 
Decrease
 
 
 
 
 
Mortality rate(5)
 
0
%
 
 
31
%
 
 
 
 
 
Decrease
 
 
 
 
 
Premium payment(6)
 
0.65
X
 
0.95
X
 
 
 
 
Decrease
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future policy benefits(7)
$
5,041,007

 
Discounted cash flow
 
Lapse rate(8)
 
0
%
 
 
13
%
 
 
 
 
 
Decrease
 
 
 
 
 
Spread over LIBOR(4)
 
0.25
%
 
 
1.50
%
 
 
 
 
 
Decrease
 
 
 
 
 
Utilization rate(9)
 
52
%
 
 
96
%
 
 
 
 
 
Increase
 
 
 
 
 
Withdrawal rate
 
See table footnote (10) below
 
 
 
 
 
Mortality rate(11)
 
0
%
 
 
14
%
 
 
 
 
 
Decrease
 
 
 
 
 
Equity volatility curve
 
16
%
 
 
25
%
 
 
 
 
 
Increase
(1)
Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table.
(2)
Represents multiples of earnings before interest, taxes, depreciation and amortization, ("EBITDA"), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments.
(3)
For universal life, lapse rates vary based on funding level and other factors. Rates are set to zero when the no lapse guarantee is fully funded and the cash value is zero.
(4)
The spread over LIBOR swap curve represents the premium added to the risk-free discount rate (i.e., LIBOR) to reflect our estimates of rates that a market participant would use to value the living benefit contracts in both the accumulation and payout phases. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because both funding agreements and living benefit contracts are insurance liabilities and are therefore senior to debt.
(5)
Universal life mortality rates are adjusted based on underwriting information. A mortality improvement assumption is also incorporated into the projection.
(6)
For universal life, policyholders are assumed to pay a multiple of commissionable target premium levels (shown above and indicated as "X"). The multiples vary by funding level and policy duration. If the resulting premium in any duration is smaller than the minimum annual premium required to maintain the no-lapse guarantee, policyholders are assumed to pay the minimum annual premium. Policyholders are assumed to stop premium payments once the no-lapse guarantee is fully funded. The range shown as of December 31, 2016 excludes multiples for the first duration since all contracts are beyond the first duration. Assumption ranges for prior periods include first duration multiples.
(7)
Future policy benefits primarily represent general account liabilities for the living benefit guarantees of the Company’s variable annuity contracts which are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.
(8)
Lapse rates are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates are also generally assumed to be lower for the period where surrender charges apply.
(9)
The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration, and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits.
(10)
The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions may vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of December 31, 2017 and 2016, the minimum withdrawal assumption rate is 78% and the maximum withdrawal assumption rate may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%.
(11)
Range reflects the mortality rate for the vast majority of business with living benefits, with policyholders ranging from 35 to 90 years old. While the majority of living benefits have a minimum age requirement, certain benefits do not have an age restriction. This results in contractholders for certain benefits with mortality rates approaching 0%. Based on historical experience, the Company applies a set of age and duration specific mortality rate adjustments compared to standard industry tables. A mortality improvement assumption is also incorporated into the overall mortality table.
(12)
Includes assets classified as fixed maturities available-for-sale.
(13)
Effective July 1, 2017, the Company recaptured the risks related to the no-lapse guarantees that were previously reinsured to UPARC and discontinued the embedded derivative accounting.
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods.
 
 
Year Ended December 31, 2017
 
 
Fixed Maturities Available-For-Sale
 
 
U.S. Government
 
Corporate Securities (5)
 
Asset-Backed Securities (6)
 
Commercial Mortgage-Backed Securities
 
 
(in thousands)
Fair value, beginning of period
 
$
0

 
$
102,556

 
$
19,856

 
$
0

Total gains (losses) (realized/unrealized):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
0

 
(2,198
)
 
4,199

 
0

Asset management fees and other income
 
0

 
0

 
0

 
0

Included in other comprehensive income (loss)
 
0

 
1,590

 
(3,178
)
 
0

Net investment income
 
0

 
158

 
112

 
0

Purchases
 
15,634

 
18,022

 
108,731

 
1,493

Sales
 
0

 
(52,287
)
 
(7,471
)
 
0

Issuances
 
0

 
0

 
0

 
0

Settlements
 
0

 
(24,770
)
 
(55,372
)
 
0

Transfers into Level 3(1)
 
0

 
42,125

 
78,159

 
0

Transfers out of Level 3(1)
 
0

 
(6,193
)
 
(34,008
)
 
(1,493
)
Other(3)
 
3,570

 
(3,582
)
 
0

 
0

Fair value, end of period
 
$
19,204

 
$
75,421

 
$
111,028

 
$
0

Unrealized gains (losses) for assets still held(2):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
0

 
$
(2,736
)
 
$
0

 
$
0

Asset management fees and other income
 
$
0

 
$
0

 
$
0

 
$
0

 
 
Year Ended December 31, 2017
 
 
Trading Account Assets
 
 
 
 
 
 
 
 
 Asset-Backed Securities (6)
 
Equity
Securities
 
Equity
Securities,
Available-for-Sale
 
Short term Investments
 
Other Long-
term
Investments
 
 
(in thousands)
Fair value, beginning of period
 
$
0

 
$
15,770

 
$
75

 
$
0

 
$
0

Total gains (losses) (realized/unrealized):
 
 
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
0

 
0

 
0

 
0

 
0

Asset management fees and other income
 
0

 
1,707

 
0

 
0

 
0

Included in other comprehensive income (loss)
 
0

 
0

 
(38
)
 
0

 
0

Net investment income
 
0

 
0

 
0

 
0

 
0

Purchases
 
0

 
0

 
0

 
8,425

 
0

Sales
 
0

 
0

 
0

 
(1
)
 
0

Issuances
 
0

 
0

 
0

 
0

 
0

Settlements
 
0

 
0

 
0

 
(7,085
)
 
0

Transfers into Level 3(1)
 
0

 
0

 
0

 
0

 
16

Transfers out of Level 3(1)
 
0

 
0

 
0

 
0

 
(16
)
Other(3)
 
0

 
11

 
0

 
0

 
0

Fair value, end of period
 
$
0

 
$
17,488

 
$
37

 
$
1,339

 
$
0

Unrealized gains (losses) for assets still held(2):
 
 
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
0

 
$
0

 
$
0

 
$
0

 
$
0

Asset management fees and other income
 
$
0

 
$
2,345

 
$
0

 
$
0

 
$
0











 
 
Year Ended December 31, 2017
 
 
Reinsurance
Recoverables
 
Receivables from Parent 
and Affiliates
 
Future Policy
Benefits
 
Policyholders' Account Balances
 
 
(in thousands)
Fair value, beginning of period
 
$
5,474,263

 
$
6,493

 
$
(5,041,007
)
 
$
(20,337
)
Total gains (losses) (realized/unrealized):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net(4)
 
(158,623
)
 
0

 
463,432

 
(30,991
)
Asset management fees and other income
 
0

 
0

 
0

 
0

Included in other comprehensive income (loss)
 
0

 
0

 
0

 
0

Net investment income
 
0

 
0

 
0

 
0

Purchases
 
902,110

 
0

 
0

 
0

Sales
 
0

 
0

 
0

 
0

Issuances
 
0

 
0

 
(875,008
)
 
0

Settlements
 
0

 
0

 
0

 
4,677

Transfers into Level 3(1)
 
0

 
0

 
0

 
0

Transfers out of Level 3(1)
 
0

 
(6,493
)
 
0

 
0

Other(3)
 
(760,101
)
 
0

 
0

 
0

Fair value, end of period
 
$
5,457,649

 
$
0

 
$
(5,452,583
)
 
$
(46,651
)
Unrealized gains (losses) for assets/liabilities still held(2):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
(315,998
)
 
$
0

 
$
313,532

 
$
(30,991
)
Asset management fees and other income
 
$
0

 
$
0

 
$
0

 
$
0


 
Year Ended December 31, 2016
 
Fixed Maturities, Available-for-Sale
 
 
Corporate Securities (5)
 
Asset-Backed
Securities (6)
 
Commercial Mortgage-Backed Securities
 
(in thousands)
Fair value, beginning of period
 
$
95,492

 
$
173,347

 
$
0

Total gains (losses) (realized/unrealized):
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
Realized investment gains (losses), net
 
(277
)
 
(891
)
 
0

Asset management fees and other income
 
0

 
0

 
0

Included in other comprehensive income (loss)
 
(1,018
)
 
158

 
0

Net investment income
 
54

 
149

 
0

Purchases
 
5,459

 
21,473

 
0

Sales
 
(9,928
)
 
(44,486
)
 
0

Issuances
 
0

 
0

 
0

Settlements
 
(10,728
)
 
(1,071
)
 
0

Transfers into Level 3(1)
 
29,881

 
48,957

 
0

Transfers out of Level 3(1)
 
(6,379
)
 
(177,780
)
 
0

Other(3)
 
0

 
0

 
0

Fair value, end of period
 
$
102,556

 
$
19,856

 
$
0

Unrealized gains (losses) for assets still held(2):
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
(560
)
 
$
(1,378
)
 
$
0

Asset management fees and other income
 
$
0

 
$
0

 
$
0


 
 
Year Ended December 31, 2016
 
 
Trading Account Assets
 
 
 
 
 
 
Asset-Backed Securities (6)
 
Equity
Securities
 
Equity
Securities
Available-For-Sale
 
Other Long-term
Investments
 
 
(in thousands)
Fair value, beginning of period
 
$
0

 
$
18,248

 
$
165

 
$
5,704

Total gains (losses) (realized/unrealized):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net(4)
 
0

 
0

 
0

 
0

Asset management fees and other income
 
(32
)
 
192

 
0

 
0

Included in other comprehensive income (loss)
 
0

 
0

 
(90
)
 
0

Net investment income
 
0

 
0

 
0

 
(67
)
Purchases
 
0

 
0

 
0

 
102

Sales
 
0

 
(5,930
)
 
0

 
0

Issuances
 
0

 
0

 
0

 
0

Settlements
 
(527
)
 
0

 
0

 
0

Transfers into Level 3(1)
 
0

 
0

 
0

 
0

Transfers out of Level 3(1)
 
0

 
0

 
0

 
(2,479
)
Other
 
559

 
3,260

 
0

 
(3,260
)
Fair value, end of period
 
$
0

 
$
15,770

 
$
75

 
$
0

Unrealized gains (losses) for assets still held(2):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
0

 
$
0

 
$
0

 
$
0

Asset management fees and other income
 
$
0

 
$
(769
)
 
$
0

 
$
0


 
 
Year Ended December 31, 2016
 
 
Reinsurance
Recoverables
 
Receivables
from Parent
and Affiliates
 
Future Policy
Benefits
 
Policyholders' Account Balances
 
 
(in thousands)
Fair value, beginning of period
 
$
4,940,011

 
$
5,000

 
$
(5,205,434
)
 
$
0

Total gains (losses) (realized/unrealized):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net(4)
 
(281,009
)
 
(13
)
 
975,823

 
(8,463
)
Asset management fees and other income
 
0

 
0

 
0

 
0

Included in other comprehensive income (loss)
 
0

 
16

 
0

 
0

Net investment income
 
0

 
0

 
0

 
0

Purchases
 
815,261

 
6,500

 
0

 
0

Sales
 
0

 
(1,987
)
 
0

 
0

Issuances
 
0

 
0

 
(811,396
)
 
0

Settlements
 
0

 
0

 
0

 
(5,972
)
Transfers into Level 3(1)
 
0

 
0

 
0

 
0

Transfers out of Level 3(1)
 
0

 
(2,464
)
 
0

 
0

Other
 
0

 
(559
)
 
0

 
(5,902
)
Fair value, end of period
 
$
5,474,263

 
$
6,493

 
$
(5,041,007
)
 
$
(20,337
)
Unrealized gains (losses) for assets/liabilities still held(2):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
4,326,977

 
$
0

 
$
866,386

 
$
(8,463
)
Asset management fees and other income
 
$
0

 
$
0

 
$
0

 
$
0

The following tables summarize the portion of changes in fair values of Level 3 assets and liabilities included in earnings and other comprehensive income for the year ended December 31, 2015, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held as of December 31, 2015.
 
 
Year Ended December 31, 2015
 
 
Fixed Maturities, Available-for-Sale
 
 
Corporate Securities (5)
 
Asset-Backed
Securities (6)
 
Commercial Mortgage-Backed Securities
 
 
(in thousands)
Total gains (losses) (realized/unrealized):
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
(1,533
)
 
$
42

 
$
0

Asset management fees and other income
 
$
0

 
$
0

 
$
0

Included in other comprehensive income (loss)
 
$
262

 
$
(939
)
 
$
0

Net investment income
 
$
30

 
$
52

 
$
0

Unrealized gains (losses) for assets still held(2):
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
(1,392
)
 
$
0

 
$
0

Asset management fees and other income
 
$
0

 
$
0

 
$
0


 
 
Year Ended December 31, 2015
 
 
Trading Account Assets
 
 
 
 
 
 
Asset-Backed Securities (6)
 
Equity
Securities
 
Equity
Securities,
Available-for-Sale
 
Other Long-
term
Investments
 
 
(in thousands)
Total gains (losses) (realized/unrealized):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
0

 
$
0

 
$
337

 
$
1,912

Asset management fees and other income
 
$
0

 
$
2,207

 
$
0

 
$
0

Included in other comprehensive income (loss)
 
$
0

 
$
0

 
$
(245
)
 
$
0

Net investment income
 
$
0

 
$
0

 
$
0

 
$
0

Unrealized gains (losses) for assets/liabilities still held(2):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
0

 
$
0

 
$
0

 
$
1,744

Asset management fees and other income
 
$
0

 
$
2,162

 
$
0

 
$
0


 
 
Year Ended December 31, 2015
 
 
Reinsurance
Recoverables
 
Receivables
from Parent
and Affiliates
 
Future 
Policy
Benefits
 
Policyholders' Account Balances
 
 
(in thousands)
Total gains (losses) (realized/unrealized):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net (4)
 
$
(635,006
)
 
$
0

 
$
505,416

 
$
0

Asset management fees and other income
 
$
0

 
$
0

 
$
0

 
$
0

Included in other comprehensive income (loss)
 
$
0

 
$
(17
)
 
$
0

 
$
0

Net investment income
 
$
0

 
$
0

 
$
0

 
$
0

Unrealized gains (losses) for assets/liabilities still held(2):
 
 
 
 
 
 
 
 
Included in earnings:
 
 
 
 
 
 
 
 
Realized investment gains (losses), net
 
$
(482,828
)
 
$
0

 
$
381,057

 
$
0

Asset management fees and other income
 
$
0

 
$
0

 
$
0

 
$
0

(1)
Transfers into or out of any level are generally reported at the value as of the beginning of the quarter in which the transfer occurs for any such assets still held at the end of the quarter.
(2)
Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts.
(3)
Other, except for Reinsurance recoverables, primarily represents reclassifications of certain assets and liabilities between reporting categories. Other for Reinsurance Recoverables for the year ended December 31, 2017, represents the Company's recapture of the risks related to the no-lapse guarantees that were previously reinsured to UPARC and the discontinuation of embedded derivative accounting, effective July 1, 2017.
(4)
Realized investment gains (losses) on Future Policy Benefits and Reinsurance Recoverables primarily represents the change in the fair value of the Company's living benefit guarantees on certain of its variable annuity contracts. Refer to Note 1 for impacts to Realized investment gains (losses) related to the Variable Annuities Recapture.
(5)
Includes U.S. corporate public, U.S. corporate private, foreign corporate public and foreign corporate private securities. Prior period amounts were aggregated to conform to current period presentation.
(6)
Includes credit-tranched securities collateralized by syndicated bank loans, sub-prime mortgages, auto loans, credit cards, education loans and other asset types.
Fair Value Disclosure Financial Instruments Not Carried at Fair Value
The table below presents the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Consolidated Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
 
 
December 31, 2017(1)
 
 
Fair Value
 
Carrying
Amount(2)
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Total
 
 
(in thousands)
Assets:
 
 
 
 
 
 
 
 
 
 
Commercial mortgage and other loans
 
$
0

 
$
0

 
$
1,111,625

 
$
1,111,625

 
$
1,083,419

Policy loans
 
0

 
0

 
1,161,101

 
1,161,101

 
1,161,101

Cash and cash equivalents
 
36,562

 
148,000

 
0

 
184,562

 
184,562

Accrued investment income
 
0

 
82,341

 
0

 
82,341

 
82,341

Receivables from parent and affiliates
 
0

 
167,545

 
0

 
167,545

 
167,545

Other assets
 
0

 
50,407

 
0

 
50,407

 
50,407

Total assets
 
$
36,562

 
$
448,293

 
$
2,272,726

 
$
2,757,581

 
$
2,729,375

Liabilities:
 
 
 
 
 
 
 
 
 
 
Policyholders’ account balances - investment contracts
 
$
0

 
$
1,178,583

 
$
276,435

 
$
1,455,018

 
$
1,458,599

Securities sold under agreements to repurchase
 
0

 
0

 
0

 
0

 
0

Cash collateral for loaned securities
 
0

 
33,169

 
0

 
33,169

 
33,169

Payables to parent and affiliates
 
0

 
223,550

 
0

 
223,550

 
223,550

Other liabilities
 
0

 
362,592

 
0

 
362,592

 
362,592

Total liabilities
 
$
0

 
$
1,797,894

 
$
276,435

 
$
2,074,329

 
$
2,077,910

 
 
December 31, 2016(1)
  
 
Fair Value
 
Carrying
Amount (2)
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Total
 
 
(in thousands)
Assets:
 
 
 
 
 
 
 
 
 
 
Commercial mortgage and other loans
 
$
0

 
$
0

 
$
1,181,582

 
$
1,181,582

 
$
1,150,381

Policy loans
 
0

 
0

 
1,166,456

 
1,166,456

 
1,166,456

Cash and cash equivalents
 
30,149

 
58,366

 
0

 
88,515

 
88,515

Accrued investment income
 
0

 
87,322

 
0

 
87,322

 
87,322

Receivables from parent and affiliates
 
0

 
76,315

 
0

 
76,315

 
76,315

Other assets
 
0

 
37,969

 
0

 
37,969

 
37,969

Total assets
 
$
30,149

 
$
259,972

 
$
2,348,038

 
$
2,638,159

 
$
2,606,958

Liabilities:
 
 
 
 
 
 
 
 
 
 
Policyholders’ account balances - investment contracts
 
$
0

 
$
1,129,378

 
$
253,007

 
$
1,382,385

 
$
1,386,099

Securities sold under agreements to repurchase
 
0

 
68,904

 
0

 
68,904

 
68,904

Cash collateral for loaned securities
 
0

 
74,976

 
0

 
74,976

 
74,976

Payables to parent and affiliates
 
0

 
73,628

 
0

 
73,628

 
73,628

Other liabilities
 
0

 
305,969

 
0

 
305,969

 
305,969

Total liabilities
 
$
0

 
$
1,652,855

 
$
253,007

 
$
1,905,862

 
$
1,909,576


(1)
Other long-term investments excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at NAV per share (or its equivalent) as a practical expedient. At December 31, 2017 and 2016, the fair values of these cost method investments were $49 million and $35 million, respectively. The carrying values of these investments were $41 million and $32 million as of December 31, 2017 and 2016, respectively.
(2)
Carrying values presented herein differ from those in the Company’s Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments. Financial statement captions excluded from the above table are not considered financial instruments.